These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adalimumab in the therapy of uveitis in childhood. Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274 [TBL] [Abstract][Full Text] [Related]
6. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital]. Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230 [TBL] [Abstract][Full Text] [Related]
7. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? Tappeiner C; Heinz C; Ganser G; Heiligenhaus A J Rheumatol; 2012 Jun; 39(6):1294-5. PubMed ID: 22661419 [No Abstract] [Full Text] [Related]
8. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061 [TBL] [Abstract][Full Text] [Related]
9. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625 [TBL] [Abstract][Full Text] [Related]
18. [Research update of anti-TNF-α biologic agents in the treatment of uveitis]. Fan F; Zhou M; Luo Y Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):285-8. PubMed ID: 23866712 [TBL] [Abstract][Full Text] [Related]
19. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients. Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756 [TBL] [Abstract][Full Text] [Related]
20. Infliximab and adalimumab for uveitis. Martel JN; Esterberg E; Nagpal A; Acharya NR Ocul Immunol Inflamm; 2012 Feb; 20(1):18-26. PubMed ID: 22324897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]